Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12076405 Heterocyclic degronimers for target protein degradation

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
February 1, 2021
0
Date of Patent
September 3, 2024
0
Patent Applicant
C4 Therapeutics
C4 Therapeutics
0
Patent Application Number
17164446
0
Patent Citations
‌
US Patent 10351568 Compositions and methods for enhancing proteasome activity
0
‌
US Patent 10414755 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
0
‌
US Patent 10905768 Heterocyclic degronimers for target protein degradation
0
‌
US Patent 10646575 Heterocyclic degronimers for target protein degradation
0
‌
US Patent 7041298 Proteolysis targeting chimeric pharmaceutical
0
‌
US Patent 7208157 Proteolysis targeting chimeric pharmaceutical
0
‌
US Patent 9125915 Antitumor agent
0
‌
US Patent 9249161 Bromodomain inhibitors and uses thereof
0
Patent Inventor Names
Andrew J. Phillips
0
Yanke Liang
0
Minsheng He
0
James A. Henderson
0
Christopher G. Nasveschuk
0
Ryan E. Michael
0
Mark E. Fitzgerald
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12076405
0
Patent Primary Examiner
‌
Joseph R Kosack
0
CPC Code
‌
C07D 401/04
0
‌
A61P 35/00
0
‌
A61P 37/00
0
‌
C07D 403/04
0
‌
A61K 47/554
0
‌
A61K 31/55
0
‌
A61K 31/547
0
‌
A61K 31/454
0
‌
A61K 31/439
0
‌
A61K 31/438
0
•••

Find more entities like US Patent 12076405 Heterocyclic degronimers for target protein degradation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo